Skip to main content
Erschienen in: Journal of Medical Systems 3/2019

01.03.2019 | Mobile & Wireless Health

Design Considerations in the Development of App-Based Oral Anticancer Medication Management Systems: a Qualitative Evaluation of Pharmacists’ and Patients’ Perspectives

verfasst von: Eskinder Eshetu Ali, Sharlene Si Ling Chan, Huan Yu Poh, Yosua Amadeus Susanto, Thendral Suganya, Jo Lene Leow, Chee Khiang Pang, Lita Chew, Kevin Yi-Lwern Yap

Erschienen in: Journal of Medical Systems | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Smartphone apps can potentially help in enhancing oral anticancer medication (OAM) adherence. Patient adoption and efficacy of such apps depends on inclusion of user-centred and evidence-based features. The objective of this study was to identify important design considerations from the perspectives of patients taking OAMs, caregivers and oncology pharmacists. The study employed a qualitative study design. Data were collected using in-depth interviews with patients (n = 15), caregivers (n = 3) and pharmacists (n = 16). Interviews were audio-recorded, transcribed verbatim and inductive thematic analysis approach was used in data analysis. Monitoring medication-related problems, medication information, replacement of or integration with current systems and accessibility of app content on devices other than smartphones were the key themes identified in the analysis. Flexible input methods for monitored data, glanceability of monitored reports/information, near real-time adherence enhancing and symptom management interventions and customisable reminder options were design considerations identified under the monitoring medication-related problems theme. Participants suggested the provision of focused and easily understandable medication information with a potential for personalisation. Integration of app-based adherence systems with patients’ electronic medical records with added mechanisms for alerts in the dispensing system was also suggested as a key design requirement to improve quality of patient care and facilitate adoption by clinicians. Finally, smartphones were the most favoured platform with optional accessibility of app content on other devices. In conclusion, important design considerations were identified through a user-centred design approach. The findings will help developers and clinicians in the design of new app-based systems and evaluation of existing ones.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Sabaté, E., Adherence to long-term therapies: Evidence for action. Switzerland: World Health Organization, 2003. Sabaté, E., Adherence to long-term therapies: Evidence for action. Switzerland: World Health Organization, 2003.
2.
Zurück zum Zitat Barillet, M., Prevost, V., Joly, F., and Clarisse, B., Oral antineoplastic agents: How do we care about adherence? Br. J. Clin. Pharmacol. 80(6):1289–1302, 2015.CrossRef Barillet, M., Prevost, V., Joly, F., and Clarisse, B., Oral antineoplastic agents: How do we care about adherence? Br. J. Clin. Pharmacol. 80(6):1289–1302, 2015.CrossRef
3.
Zurück zum Zitat Greer, J. A., Amoyal, N., Nisotel, L., Fishbein, J. N., MacDonald, J., Stagl, J., Lennes, I., Temel, J. S., Safren, S. A., and Pirl, W. F., A systematic review of adherence to oral antineoplastic therapies. Oncologist 21(3):354–376, 2016.CrossRef Greer, J. A., Amoyal, N., Nisotel, L., Fishbein, J. N., MacDonald, J., Stagl, J., Lennes, I., Temel, J. S., Safren, S. A., and Pirl, W. F., A systematic review of adherence to oral antineoplastic therapies. Oncologist 21(3):354–376, 2016.CrossRef
4.
Zurück zum Zitat Huang, W. C., Chen, C. Y., Lin, S. J., and Chang, C. S., Medication adherence to oral anticancer drugs: Systematic review. Expert Rev. Anticancer Ther. 16(4):423–432, 2016.CrossRef Huang, W. C., Chen, C. Y., Lin, S. J., and Chang, C. S., Medication adherence to oral anticancer drugs: Systematic review. Expert Rev. Anticancer Ther. 16(4):423–432, 2016.CrossRef
5.
Zurück zum Zitat Shafrin, J., Sullivan, J., Chou, J. W., Neely, M. N., Doan, J. F., and Maclean, J. R., The effect of medication nonadherence on progression-free survival among patients with renal cell carcinoma. Cancer Manag. Res. 9:731–739, 2017.CrossRef Shafrin, J., Sullivan, J., Chou, J. W., Neely, M. N., Doan, J. F., and Maclean, J. R., The effect of medication nonadherence on progression-free survival among patients with renal cell carcinoma. Cancer Manag. Res. 9:731–739, 2017.CrossRef
6.
Zurück zum Zitat Chirgwin, J. H., Giobbie-Hurder, A., Coates, A. S., Price, K. N., Ejlertsen, B., Debled, M., Gelber, R. D., Goldhirsch, A., Smith, I., Rabaglio, M., Forbes, J. F., Neven, P., Lang, I., Colleoni, M., and Thurlimann, B., Treatment adherence and its impact on disease-free survival in the breast international group 1-98 trial of tamoxifen and letrozole, alone and in sequence. J. Clin. Oncol. 34(21):2452–2459, 2016.CrossRef Chirgwin, J. H., Giobbie-Hurder, A., Coates, A. S., Price, K. N., Ejlertsen, B., Debled, M., Gelber, R. D., Goldhirsch, A., Smith, I., Rabaglio, M., Forbes, J. F., Neven, P., Lang, I., Colleoni, M., and Thurlimann, B., Treatment adherence and its impact on disease-free survival in the breast international group 1-98 trial of tamoxifen and letrozole, alone and in sequence. J. Clin. Oncol. 34(21):2452–2459, 2016.CrossRef
7.
Zurück zum Zitat Cutler, R. L., Fernandez-Llimos, F., Frommer, M., Benrimoj, C., and Garcia-Cardenas, V., Economic impact of medication nonadherence by disease groups: A systematic review. BMJ Open 8:e016982, 2018.PubMedPubMedCentral Cutler, R. L., Fernandez-Llimos, F., Frommer, M., Benrimoj, C., and Garcia-Cardenas, V., Economic impact of medication nonadherence by disease groups: A systematic review. BMJ Open 8:e016982, 2018.PubMedPubMedCentral
8.
Zurück zum Zitat Latremouille-Viau, D., Guerin, A., Gagnon-Sanschagrin, P., Dea, K., Cohen, B. G., and Joseph, G. J., Health care resource utilization and costs in patients with chronic myeloid leukemia with better adherence to tyrosine kinase inhibitors and increased molecular monitoring frequency. J. Manag. Care Spec. Pharm. 23(2):214–224, 2017.PubMed Latremouille-Viau, D., Guerin, A., Gagnon-Sanschagrin, P., Dea, K., Cohen, B. G., and Joseph, G. J., Health care resource utilization and costs in patients with chronic myeloid leukemia with better adherence to tyrosine kinase inhibitors and increased molecular monitoring frequency. J. Manag. Care Spec. Pharm. 23(2):214–224, 2017.PubMed
9.
Zurück zum Zitat Gandhi, S., Day, L., Paramsothy, T., Giotis, A., Ford, M., Boudreau, A., and Pasetka, M., Oral anticancer medication adherence, toxicity reporting, and counseling: A study comparing health care providers and patients. J. Oncol. Pract. 11(6):498–504, 2015.CrossRef Gandhi, S., Day, L., Paramsothy, T., Giotis, A., Ford, M., Boudreau, A., and Pasetka, M., Oral anticancer medication adherence, toxicity reporting, and counseling: A study comparing health care providers and patients. J. Oncol. Pract. 11(6):498–504, 2015.CrossRef
10.
Zurück zum Zitat Verbrugghe, M., Verhaeghe, S., Lauwaert, K., Beeckman, D., and Van Hecke, A., Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: A systematic review. Cancer Treat. Rev. 39(6):610–621, 2013.CrossRef Verbrugghe, M., Verhaeghe, S., Lauwaert, K., Beeckman, D., and Van Hecke, A., Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: A systematic review. Cancer Treat. Rev. 39(6):610–621, 2013.CrossRef
11.
Zurück zum Zitat Foulon, V., Schoffski, P., and Wolter, P., Patient adherence to oral anticancer drugs: An emerging issue in modern oncology. Acta Clin. Belg. 66(2):85–96, 2011.PubMed Foulon, V., Schoffski, P., and Wolter, P., Patient adherence to oral anticancer drugs: An emerging issue in modern oncology. Acta Clin. Belg. 66(2):85–96, 2011.PubMed
12.
Zurück zum Zitat Car, L. T., Papachristou, N., Urch, C., Majeed, A., Atun, R., Car, J., and Vincent, C., Prioritizing medication safety in care of people with cancer: Clinicians’ views on main problems and solutions. J. Glob. Health 7 (1), 2017. https://doi.org/10.7189/jogh.07.011001. Car, L. T., Papachristou, N., Urch, C., Majeed, A., Atun, R., Car, J., and Vincent, C., Prioritizing medication safety in care of people with cancer: Clinicians’ views on main problems and solutions. J. Glob. Health 7 (1), 2017. https://​doi.​org/​10.​7189/​jogh.​07.​011001.
13.
Zurück zum Zitat Hershman, D. L., Sticking to it: Improving outcomes by increasing adherence. J. Clin. Oncol. 34(21):2440–2442, 2016.CrossRef Hershman, D. L., Sticking to it: Improving outcomes by increasing adherence. J. Clin. Oncol. 34(21):2440–2442, 2016.CrossRef
14.
Zurück zum Zitat Neven, P., Markopoulos, C., Tanner, M., Marty, M., Kreienberg, R., Atkins, L., Franquet, A., Gnant, M., Neciosup, S., Tesarova, P., Barni, S., and Deschamp, V., The impact of educational materials on compliance and persistence rates with adjuvant aromatase inhibitor treatment: First-year results from the compliance of aromatase inhibitors assessment in daily practice through educational approach (cariatide) study. Breast 23(4):393–399, 2014.CrossRef Neven, P., Markopoulos, C., Tanner, M., Marty, M., Kreienberg, R., Atkins, L., Franquet, A., Gnant, M., Neciosup, S., Tesarova, P., Barni, S., and Deschamp, V., The impact of educational materials on compliance and persistence rates with adjuvant aromatase inhibitor treatment: First-year results from the compliance of aromatase inhibitors assessment in daily practice through educational approach (cariatide) study. Breast 23(4):393–399, 2014.CrossRef
15.
Zurück zum Zitat Gebbia, V., Bellavia, M., Banna, G. L., Russo, P., Ferrau, F., Tralongo, P., and Borsellino, N., Treatment monitoring program for implementation of adherence to second-line erlotinib for advanced non-small-cell lung cancer. Clin. Lung Cancer 14(4):390–398, 2013.CrossRef Gebbia, V., Bellavia, M., Banna, G. L., Russo, P., Ferrau, F., Tralongo, P., and Borsellino, N., Treatment monitoring program for implementation of adherence to second-line erlotinib for advanced non-small-cell lung cancer. Clin. Lung Cancer 14(4):390–398, 2013.CrossRef
16.
Zurück zum Zitat Mathes, T., Antoine, S.-L., Pieper, D., and Eikermann, M., Adherence enhancing interventions for oral anticancer agents: A systematic review. Cancer Treat. Rev. 40(1):102–108, 2014.CrossRef Mathes, T., Antoine, S.-L., Pieper, D., and Eikermann, M., Adherence enhancing interventions for oral anticancer agents: A systematic review. Cancer Treat. Rev. 40(1):102–108, 2014.CrossRef
17.
Zurück zum Zitat Sommers, R. M., Miller, K., and Berry, D. L., Feasibility pilot on medication adherence and knowledge in ambulatory patients with gastrointestinal cancer. Oncol. Nurs. Forum 39(4):E373–E379, 2012.CrossRef Sommers, R. M., Miller, K., and Berry, D. L., Feasibility pilot on medication adherence and knowledge in ambulatory patients with gastrointestinal cancer. Oncol. Nurs. Forum 39(4):E373–E379, 2012.CrossRef
18.
Zurück zum Zitat Hadji, P., Blettner, M., Harbeck, N., Jackisch, C., Luck, H. J., Windemuth-Kieselbach, C., Zaun, S., and Kreienberg, R., The patient's anastrozole compliance to therapy (pact) program: A randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancer. Ann. Oncol. 24(6):1505–1512, 2013.CrossRef Hadji, P., Blettner, M., Harbeck, N., Jackisch, C., Luck, H. J., Windemuth-Kieselbach, C., Zaun, S., and Kreienberg, R., The patient's anastrozole compliance to therapy (pact) program: A randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancer. Ann. Oncol. 24(6):1505–1512, 2013.CrossRef
19.
Zurück zum Zitat Kav, S., and Tokdemir, G., The effect of structured education to patients receiving oral agents for cancer treatment on medication adherence and self-efficacy. Asia Pac. J. Oncol. Nurs. 4(4):290, 2017.CrossRef Kav, S., and Tokdemir, G., The effect of structured education to patients receiving oral agents for cancer treatment on medication adherence and self-efficacy. Asia Pac. J. Oncol. Nurs. 4(4):290, 2017.CrossRef
20.
Zurück zum Zitat Spoelstra, S. L., Given, C. W., Sikorskii, A., Coursaris, C. K., Majumder, A., DeKoekkoek, T., Schueller, M., and Given, B. A., Proof of concept of a mobile health short message service text message intervention that promotes adherence to oral anticancer agent medications: A randomized controlled trial. Telemed. J. E Health 22(6):497–506, 2016.CrossRef Spoelstra, S. L., Given, C. W., Sikorskii, A., Coursaris, C. K., Majumder, A., DeKoekkoek, T., Schueller, M., and Given, B. A., Proof of concept of a mobile health short message service text message intervention that promotes adherence to oral anticancer agent medications: A randomized controlled trial. Telemed. J. E Health 22(6):497–506, 2016.CrossRef
21.
Zurück zum Zitat Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., Sivaramalingam, B., Iserman, E., Mustafa, R. A., Jedraszewski, D., Cotoi, C., and Haynes, R.B., Interventions for enhancing medication adherence. Cochrane Database Syst. Rev. (11):Cd000011, 2014. Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., Sivaramalingam, B., Iserman, E., Mustafa, R. A., Jedraszewski, D., Cotoi, C., and Haynes, R.B., Interventions for enhancing medication adherence. Cochrane Database Syst. Rev. (11):Cd000011, 2014.
22.
Zurück zum Zitat Car, J., Tan, W. S., Huang, Z., Sloot, P., and Franklin, B. D., Ehealth in the future of medications management: Personalisation, monitoring and adherence. BMC Med. 15(1):73, 2017.CrossRef Car, J., Tan, W. S., Huang, Z., Sloot, P., and Franklin, B. D., Ehealth in the future of medications management: Personalisation, monitoring and adherence. BMC Med. 15(1):73, 2017.CrossRef
26.
Zurück zum Zitat Haase, J., Farris, K. B., and Dorsch, M. P., Mobile applications to improve medication adherence. Telemed. J. E Health 23(2):75–79, 2017.CrossRef Haase, J., Farris, K. B., and Dorsch, M. P., Mobile applications to improve medication adherence. Telemed. J. E Health 23(2):75–79, 2017.CrossRef
27.
Zurück zum Zitat Spoelstra, S. L., and Sansoucie, H., Putting evidence into practice: Evidence-based interventions for oral agents for cancer. Clin. J. Oncol. Nurs. 19(3 Suppl):60–72, 2015.CrossRef Spoelstra, S. L., and Sansoucie, H., Putting evidence into practice: Evidence-based interventions for oral agents for cancer. Clin. J. Oncol. Nurs. 19(3 Suppl):60–72, 2015.CrossRef
28.
Zurück zum Zitat Tricarico, C., Peters, R., Som, A., Javaherian, K., and Ross, W., Epxmedtracking: Feasibility evaluation of an sms-based medication adherence tracking system in community practice. JMIR Res. Protoc. 6(5):e87, 2017.CrossRef Tricarico, C., Peters, R., Som, A., Javaherian, K., and Ross, W., Epxmedtracking: Feasibility evaluation of an sms-based medication adherence tracking system in community practice. JMIR Res. Protoc. 6(5):e87, 2017.CrossRef
29.
Zurück zum Zitat Marcum, Z. A., Sevick, M. A., and Handler, S. M., Medication nonadherence: A diagnosable and treatable medical condition. JAMA 309(20):2105–2106, 2013.CrossRef Marcum, Z. A., Sevick, M. A., and Handler, S. M., Medication nonadherence: A diagnosable and treatable medical condition. JAMA 309(20):2105–2106, 2013.CrossRef
30.
Zurück zum Zitat de Vries, S. T., Denig, P., Lasheras Ruiz, C., Houyez, F., Wong, L., Sutcliffe, A., PGM, M., and Consortium IMIW-RWPb, Interest in a mobile app for two-way risk communication: A survey study among european healthcare professionals and patients. Drug Saf., 2018. https://doi.org/10.1007/s40264-018-0648-0. de Vries, S. T., Denig, P., Lasheras Ruiz, C., Houyez, F., Wong, L., Sutcliffe, A., PGM, M., and Consortium IMIW-RWPb, Interest in a mobile app for two-way risk communication: A survey study among european healthcare professionals and patients. Drug Saf., 2018. https://​doi.​org/​10.​1007/​s40264-018-0648-0.
32.
Zurück zum Zitat Azevedo, R., Bernardes, M., Fonseca, J., and Lima, A., Smartphone application for rheumatoid arthritis self-management: Cross-sectional study revealed the usefulness, willingness to use and patients' needs. Rheumatol. Int. 35(10):1675–1685, 2015.CrossRef Azevedo, R., Bernardes, M., Fonseca, J., and Lima, A., Smartphone application for rheumatoid arthritis self-management: Cross-sectional study revealed the usefulness, willingness to use and patients' needs. Rheumatol. Int. 35(10):1675–1685, 2015.CrossRef
33.
Zurück zum Zitat Israni, A., Dean, C., Kasel, B., Berndt, L., Wildebush, W., and Wang, C. J., Why do patients forget to take immunosuppression medications and miss appointments: Can a mobile phone app help? JMIR Publ. Health Surveill. 2(1):e15, 2016.CrossRef Israni, A., Dean, C., Kasel, B., Berndt, L., Wildebush, W., and Wang, C. J., Why do patients forget to take immunosuppression medications and miss appointments: Can a mobile phone app help? JMIR Publ. Health Surveill. 2(1):e15, 2016.CrossRef
34.
Zurück zum Zitat Kessel, K. A., Vogel, M. M., Schmidt-Graf, F., and Combs, S. E., Mobile apps in oncology: A survey on health care professionals' attitude toward telemedicine, mhealth, and oncological apps. J. Med. Internet Res. 18(11):e312, 2016.CrossRef Kessel, K. A., Vogel, M. M., Schmidt-Graf, F., and Combs, S. E., Mobile apps in oncology: A survey on health care professionals' attitude toward telemedicine, mhealth, and oncological apps. J. Med. Internet Res. 18(11):e312, 2016.CrossRef
35.
Zurück zum Zitat Kessel KA, Vogel MME, Kessel C, Bier H, Biedermann T, Friess H, Herschbach P, von Eisenhart-Rothe R, Meyer B, Kiechle M, Keller U, Peschel C, Schmid RM, Combs SE (2017) Mobile health in oncology: A patient survey about app-assisted cancer care. JMIR Mhealth Uhealth 5 (6):e81. Kessel KA, Vogel MME, Kessel C, Bier H, Biedermann T, Friess H, Herschbach P, von Eisenhart-Rothe R, Meyer B, Kiechle M, Keller U, Peschel C, Schmid RM, Combs SE (2017) Mobile health in oncology: A patient survey about app-assisted cancer care. JMIR Mhealth Uhealth 5 (6):e81.
36.
Zurück zum Zitat Ali, E. E., Teo, A. K. S., Goh, S. X. L., Chew, L., and Yap, K. Y., MedAd-AppQ: A quality assessment tool for medication adherence apps on iOS and Android platforms. Res. Soc. Adm. Pharm. 14:1125–1133, 2018. Ali, E. E., Teo, A. K. S., Goh, S. X. L., Chew, L., and Yap, K. Y., MedAd-AppQ: A quality assessment tool for medication adherence apps on iOS and Android platforms. Res. Soc. Adm. Pharm. 14:1125–1133, 2018.
37.
Zurück zum Zitat Dayer, L. E., Shilling, R., Van Valkenburg, M., Martin, B. C., Gubbins, P. O., Hadden, K., and Heldenbrand, S., Assessing the medication adherence app marketplace from the health professional and consumer vantage points. JMIR Mhealth Uhealth 5(4):e45, 2017.CrossRef Dayer, L. E., Shilling, R., Van Valkenburg, M., Martin, B. C., Gubbins, P. O., Hadden, K., and Heldenbrand, S., Assessing the medication adherence app marketplace from the health professional and consumer vantage points. JMIR Mhealth Uhealth 5(4):e45, 2017.CrossRef
38.
Zurück zum Zitat Santo, K., Richtering, S. S., Chalmers, J., Thiagalingam, A., Chow, C. K., and Redfern, J., Mobile phone apps to improve medication adherence: A systematic stepwise process to identify high-quality apps. JMIR Mhealth Uhealth 4(4):e132, 2016.CrossRef Santo, K., Richtering, S. S., Chalmers, J., Thiagalingam, A., Chow, C. K., and Redfern, J., Mobile phone apps to improve medication adherence: A systematic stepwise process to identify high-quality apps. JMIR Mhealth Uhealth 4(4):e132, 2016.CrossRef
39.
Zurück zum Zitat Ahmed, I., Ahmad, N. S., Ali, S., Ali, S., George, A., Saleem Danish, H., Uppal, E., Soo, J., Mobasheri, M. H., King, D., Cox, B., and Darzi, A., Medication adherence apps: Review and content analysis. JMIR Mhealth Uhealth 6(3):e62, 2018.CrossRef Ahmed, I., Ahmad, N. S., Ali, S., Ali, S., George, A., Saleem Danish, H., Uppal, E., Soo, J., Mobasheri, M. H., King, D., Cox, B., and Darzi, A., Medication adherence apps: Review and content analysis. JMIR Mhealth Uhealth 6(3):e62, 2018.CrossRef
40.
Zurück zum Zitat McCurdie, T., Taneva, S., Casselman, M., Yeung, M., McDaniel, C., Ho, W., and Cafazzo, J., Mhealth consumer apps: The case for user-centered design. Biomed. Instrum. Technol. 46(S2):49–56, 2012.CrossRef McCurdie, T., Taneva, S., Casselman, M., Yeung, M., McDaniel, C., Ho, W., and Cafazzo, J., Mhealth consumer apps: The case for user-centered design. Biomed. Instrum. Technol. 46(S2):49–56, 2012.CrossRef
41.
Zurück zum Zitat Bernhard, G., Mahler, C., Seidling, H. M., Stützle, M., Ose, D., Baudendistel, I., Wensing, M., and Szecsenyi, J., Developing a shared patient-centered, web-based medication platform for type 2 diabetes patients and their health care providers: Qualitative study on user requirements. J. Med. Internet Res. 20(3):e105, 2018.CrossRef Bernhard, G., Mahler, C., Seidling, H. M., Stützle, M., Ose, D., Baudendistel, I., Wensing, M., and Szecsenyi, J., Developing a shared patient-centered, web-based medication platform for type 2 diabetes patients and their health care providers: Qualitative study on user requirements. J. Med. Internet Res. 20(3):e105, 2018.CrossRef
42.
Zurück zum Zitat Williamson, S. S., Gorman, P. N., and Jimison, H. B., A mobile/web app for long distance caregivers of older adults: Functional requirements and design implications from a user centered design process. AMIA Annu. Symp. Proc. 2014:1960–1969, 2014. Williamson, S. S., Gorman, P. N., and Jimison, H. B., A mobile/web app for long distance caregivers of older adults: Functional requirements and design implications from a user centered design process. AMIA Annu. Symp. Proc. 2014:1960–1969, 2014.
43.
Zurück zum Zitat Paolella, G. A., Boyd, A. D., Wirth, S. M., Cuellar, S., Venepalli, N. K., and Crawford, S. Y., Adherence to oral anticancer medications: Evolving interprofessional roles and pharmacist workforce considerations. Pharmacy (Basel, Switzerland) 6(1):23, 2018. Paolella, G. A., Boyd, A. D., Wirth, S. M., Cuellar, S., Venepalli, N. K., and Crawford, S. Y., Adherence to oral anticancer medications: Evolving interprofessional roles and pharmacist workforce considerations. Pharmacy (Basel, Switzerland) 6(1):23, 2018.
44.
Zurück zum Zitat Hsu, G. I.-H., Crawford, S. Y., Paolella, G., Cuellar, S., Wirth, S. M., Venepalli, N. K., Wang, E., Hughes, D., and Boyd, A. D., Design of customized mobile application for patient adherence to oral anticancer medications utilizing user-centered design. J. Biocommun. 41(1):5–14, 2017.CrossRef Hsu, G. I.-H., Crawford, S. Y., Paolella, G., Cuellar, S., Wirth, S. M., Venepalli, N. K., Wang, E., Hughes, D., and Boyd, A. D., Design of customized mobile application for patient adherence to oral anticancer medications utilizing user-centered design. J. Biocommun. 41(1):5–14, 2017.CrossRef
45.
Zurück zum Zitat Fishbein, J. N., Nisotel, L. E., MacDonald, J. J., Amoyal Pensak, N., Jacobs, J. M., Flanagan, C., Jethwani, K., and Greer, J. A., Mobile application to promote adherence to oral chemotherapy and symptom management: A protocol for design and development. JMIR Res. Protoc. 6(4):e62, 2017.CrossRef Fishbein, J. N., Nisotel, L. E., MacDonald, J. J., Amoyal Pensak, N., Jacobs, J. M., Flanagan, C., Jethwani, K., and Greer, J. A., Mobile application to promote adherence to oral chemotherapy and symptom management: A protocol for design and development. JMIR Res. Protoc. 6(4):e62, 2017.CrossRef
46.
Zurück zum Zitat Whiteley, L., Brown, L., Lally, M., Heck, N., and van den Berg, J. J., A mobile gaming intervention to increase adherence to antiretroviral treatment for youth living with hiv: Development guided by the information, motivation, and behavioral skills model. JMIR Mhealth Uhealth 6(4):e96, 2018.CrossRef Whiteley, L., Brown, L., Lally, M., Heck, N., and van den Berg, J. J., A mobile gaming intervention to increase adherence to antiretroviral treatment for youth living with hiv: Development guided by the information, motivation, and behavioral skills model. JMIR Mhealth Uhealth 6(4):e96, 2018.CrossRef
48.
Zurück zum Zitat Fraccaro, P., Vigo, M., Balatsoukas, P., van der Veer, S. N., Hassan, L., Williams, R., Wood, G., Sinha, S., Buchan, I., and Peek, N., Presentation of laboratory test results in patient portals: Influence of interface design on risk interpretation and visual search behaviour. BMC Med. Inform. Decis. Mak. 18(1):11, 2018.CrossRef Fraccaro, P., Vigo, M., Balatsoukas, P., van der Veer, S. N., Hassan, L., Williams, R., Wood, G., Sinha, S., Buchan, I., and Peek, N., Presentation of laboratory test results in patient portals: Influence of interface design on risk interpretation and visual search behaviour. BMC Med. Inform. Decis. Mak. 18(1):11, 2018.CrossRef
49.
Zurück zum Zitat Ali, E. E., Cheung, K. L., Lee, C. P., Leow, J. L., Yap, K. Y., and Chew, L., Prevalence and determinants of adherence to oral adjuvant endocrine therapy among breast cancer patients in Singapore. Asia Pac. J. Oncol. Nurs. 4(4):283–289, 2017.CrossRef Ali, E. E., Cheung, K. L., Lee, C. P., Leow, J. L., Yap, K. Y., and Chew, L., Prevalence and determinants of adherence to oral adjuvant endocrine therapy among breast cancer patients in Singapore. Asia Pac. J. Oncol. Nurs. 4(4):283–289, 2017.CrossRef
50.
Zurück zum Zitat Braun, V., and Clarke, V., Using thematic analysis in psychology. Qual. Res. Psychol. 3(2):77–101, 2006.CrossRef Braun, V., and Clarke, V., Using thematic analysis in psychology. Qual. Res. Psychol. 3(2):77–101, 2006.CrossRef
52.
Zurück zum Zitat Mirkovic, J., Kaufman, D. R., and Ruland, C. M., Supporting cancer patients in illness management: Usability evaluation of a mobile app. JMIR Mhealth Uhealth 2(3):e33, 2014.CrossRef Mirkovic, J., Kaufman, D. R., and Ruland, C. M., Supporting cancer patients in illness management: Usability evaluation of a mobile app. JMIR Mhealth Uhealth 2(3):e33, 2014.CrossRef
53.
Zurück zum Zitat Darlow, S., and Wen, K.-Y., Development testing of mobile health interventions for cancer patient self-management: A review. Health Inform. J 22(3):633–650, 2016.CrossRef Darlow, S., and Wen, K.-Y., Development testing of mobile health interventions for cancer patient self-management: A review. Health Inform. J 22(3):633–650, 2016.CrossRef
54.
Zurück zum Zitat Whittaker, R., Merry, S., Dorey, E., and Maddison, R., A development and evaluation process for mhealth interventions: Examples from New Zealand. J. Health. Commun. 17(Suppl 1):11–21, 2012.CrossRef Whittaker, R., Merry, S., Dorey, E., and Maddison, R., A development and evaluation process for mhealth interventions: Examples from New Zealand. J. Health. Commun. 17(Suppl 1):11–21, 2012.CrossRef
56.
Zurück zum Zitat Joyce, G., Lilley, M., Barker, T., and Jefferies, A., Mobile application usability: Heuristic evaluation and evaluation of heuristics. In: Advances in human factors, software, and systems engineering. Springer International Publishing, 77–86, 2016. Joyce, G., Lilley, M., Barker, T., and Jefferies, A., Mobile application usability: Heuristic evaluation and evaluation of heuristics. In: Advances in human factors, software, and systems engineering. Springer International Publishing, 77–86, 2016.
57.
Zurück zum Zitat Alpert, J. M., Morris, B. B., Thomson, M. D., Matin, K., and Brown, R. F., Implications of patient portal transparency in oncology: Qualitative interview study on the experiences of patients, oncologists, and medical informaticists. JMIR Cancer 4(1):e5, 2018.CrossRef Alpert, J. M., Morris, B. B., Thomson, M. D., Matin, K., and Brown, R. F., Implications of patient portal transparency in oncology: Qualitative interview study on the experiences of patients, oncologists, and medical informaticists. JMIR Cancer 4(1):e5, 2018.CrossRef
58.
Zurück zum Zitat Finitsis, D. J., Pellowski, J. A., and Johnson, B. T., Text message intervention designs to promote adherence to antiretroviral therapy (art): A meta-analysis of randomized controlled trials. PloS One 9(2):e88166, 2014.CrossRef Finitsis, D. J., Pellowski, J. A., and Johnson, B. T., Text message intervention designs to promote adherence to antiretroviral therapy (art): A meta-analysis of randomized controlled trials. PloS One 9(2):e88166, 2014.CrossRef
59.
Zurück zum Zitat Liu, X., Lewis, J. J., Zhang, H., Lu, W., Zhang, S., Zheng, G., Bai, L., Li, J., Li, X., Chen, H., Liu, M., Chen, R., Chi, J., Lu, J., Huan, S., Cheng, S., Wang, L., Jiang, S., Chin, D. P., and Fielding, K. L., Effectiveness of electronic reminders to improve medication adherence in tuberculosis patients: A cluster-randomised trial. PLoS Med. 12(9):e1001876, 2015.CrossRef Liu, X., Lewis, J. J., Zhang, H., Lu, W., Zhang, S., Zheng, G., Bai, L., Li, J., Li, X., Chen, H., Liu, M., Chen, R., Chi, J., Lu, J., Huan, S., Cheng, S., Wang, L., Jiang, S., Chin, D. P., and Fielding, K. L., Effectiveness of electronic reminders to improve medication adherence in tuberculosis patients: A cluster-randomised trial. PLoS Med. 12(9):e1001876, 2015.CrossRef
60.
61.
62.
Zurück zum Zitat Cheng, C., and Dunn, M., How well are health information websites displayed on mobile phones? Implications for the readability of health information. Health Promot. J. Austr. 28(1):15–20, 2017.CrossRef Cheng, C., and Dunn, M., How well are health information websites displayed on mobile phones? Implications for the readability of health information. Health Promot. J. Austr. 28(1):15–20, 2017.CrossRef
Metadaten
Titel
Design Considerations in the Development of App-Based Oral Anticancer Medication Management Systems: a Qualitative Evaluation of Pharmacists’ and Patients’ Perspectives
verfasst von
Eskinder Eshetu Ali
Sharlene Si Ling Chan
Huan Yu Poh
Yosua Amadeus Susanto
Thendral Suganya
Jo Lene Leow
Chee Khiang Pang
Lita Chew
Kevin Yi-Lwern Yap
Publikationsdatum
01.03.2019
Verlag
Springer US
Erschienen in
Journal of Medical Systems / Ausgabe 3/2019
Print ISSN: 0148-5598
Elektronische ISSN: 1573-689X
DOI
https://doi.org/10.1007/s10916-019-1168-x

Weitere Artikel der Ausgabe 3/2019

Journal of Medical Systems 3/2019 Zur Ausgabe